| Drug Type Small molecule drug | 
| Synonyms | 
| Target | 
| Action inhibitors | 
| Mechanism STK17A inhibitors(serine/threonine kinase 17a inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Molecular FormulaC21H25N5O3 | 
| InChIKeyYCFFONJEHNSECY-UHFFFAOYSA-N | 
| CAS Registry2910938-59-7 | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Glioblastoma Multiforme | Preclinical | Germany  | 09 Jun 2022 | 





